MarginsXMarginsX
Home › Data Desk › Relmada Therapeutics Inc. reports $5.7M of cash, about 1.3 months at its recent burn

MarginsX Data Desk · Quarterly results · Early-stage clinical trials · Oncology · Late-stage clinical trials

Relmada Therapeutics Inc. reports $5.7M of cash, about 1.3 months at its recent burn

Relmada Therapeutics Inc. (RLMD) filed its 10-Q on Nov 12, 2026, covering the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 12, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 12, 2026.

Line chart of Relmada Therapeutics Inc. (RLMD) daily closes from Jul 6, 2026 to Nov 12, 2026, with the results filing on Nov 12, 2026 marked.

Revenue and margins

The net loss was $13.9M. (SEC XBRL company facts, 10-Q, Nov 12, 2026)

Balance sheet

Cash was $5.7M at Sep 30, 2026, against $11.3M at Jun 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

Shares outstanding were 106.7 million, against 106.7 million at Jun 30, 2026. (SEC XBRL company facts, 10-Q, Nov 12, 2026)

At its recent quarterly burn of $13.0M, that cash lasts about 1.3 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

The stock

The Nasdaq screener puts its market value at $443.9M. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/RLMD)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameRelmada Therapeutics Inc.Source2026-11-13
Cash5,720,325 USDSource2026-09-30
Runway1.3 monthsSource2026-09-30
WhoRelmada Therapeutics Inc. (RLMD)Source2026-11-13
SymbolRLMDSource2026-11-13
Form10-QSource2026-11-12
FiledNov 12, 2026Source2026-11-12
Period endSep 30, 2026Source2026-11-12
Net loss13,862,188 USDSource2026-11-12
Net income-13,862,188 USDSource2026-11-12
Cash prior11,334,370 USDSource2026-11-12
Prior endJun 30, 2026Source2026-11-12
Shares106,694,846 sharesSource2026-11-12
Shares prior106,669,846 sharesSource2026-11-12
Burn abs12,963,862.25 USDSource2026-09-30
Burn-12,963,862.25 USDSource2026-09-30
Cap443,850,559 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS